NCT01872845View on ClinicalTrials.gov

A Trial Comparing the Effect of Pravastatin and Rosuvastatin on Atherosclerosis Progression Measured by Carotid Intima Media Thickness in Patients With Coronary Artery Disease After Biolimus Eluting Stent (Nobori®) Implantation: CPR IMT

NACompletedINTERVENTIONAL

Enrollment

671

Participants

Timeline

Start Date

June 12, 2013

Primary Completion Date

May 25, 2017

Study Completion Date

May 25, 2017

Conditions

Coronary Artery Occlusive Disease

Interventions

DRUG

Pravastatin 40mg

Pravastatin 40mg PO daily for 1year from the day of BES implantation

DRUG

Rosuvastatin

Rosuvastatin 20mg PO daily for 1year from the day of BES implantation

Trial Locations (1)

120-752

Severance Hospital, Seoul

All Listed Sponsors

lead

Yonsei University

OTHER

NCT01872845 - A Trial Comparing the Effect of Pravastatin and Rosuvastatin on Atherosclerosis Progression Measured by Carotid Intima Media Thickness in Patients With Coronary Artery Disease After Biolimus Eluting Stent (Nobori®) Implantation: CPR IMT | Biotech Hunter | Biotech Hunter